Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of IPI-926 versus placebo in advanced chondrosarcoma
2010-024518-74Phase 2Completed
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chondrosarcoma comparing IPI-926 with Placebo (2 arms). Primary endpoint: Progression-free survival. Started Feb 2011; status: completed.
02
Drugs
patidegib
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on 2010-024518-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024518-74.